Allianz Asset Management
FBIO icon

Allianz Asset Management’s Fortress Biotech FBIO Stock Holding History

Allianz Asset Management’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2,889
Closed -$82K – 2435
2020
Q1 		$82K Buy
+2,889
New +$95.9K ﹤0.01% 2399
2013
Q4 		– Sell
-11,053
Closed -$1.16M – 1872
2013
Q3 		$1.16M Buy
11,053
+1,186
+12% +$145K ﹤0.01% 1336
2013
Q2 		$1.27M Buy
+9,867
New +$1.45M ﹤0.01% 1301

Other funds holding FBIO

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Allianz Asset Management's FBIO Position: Q2 2020 in Review

Allianz Asset Management sold out of Fortress Biotech (FBIO) in Q2 2020, closing a stake of 2,889 shares — an estimated $82K sold.

Allianz Asset Management first reported a position in FBIO in Q2 2013 and held it in 3 quarters. The position peaked at $1.27M in Q2 2013. 73 funds tracked by Wall St. Rank hold FBIO as of Q2 2020.

  • Allianz Asset Management reported no remaining Fortress Biotech position as of Q2 2020 after selling out during the quarter.
  • Allianz Asset Management sold 2,889 Fortress Biotech shares in Q2 2020, an estimated $82K.
  • Allianz Asset Management first reported a position in Fortress Biotech in Q2 2013 and held it in 3 quarters.
  • Allianz Asset Management's Fortress Biotech position peaked at $1.27M in Q2 2013.
  • 73 funds tracked by Wall St. Rank held Fortress Biotech as of Q2 2020.

Based on Allianz Asset Management's 13F filing for Q2 2020, filed 14 Aug 2020.